Drug Shortage Report for HYDREA
Report ID | 121262 |
Drug Identification Number | 00465283 |
Brand name | HYDREA CAP 500MG |
Common or Proper name | HYDROXYUREA |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | HYDROXYUREA |
Strength(s) | 500MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 1X100 |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-08-01 |
Actual start date | 2020-08-01 |
Estimated end date | 2020-10-14 |
Actual end date | 2020-10-14 |
Shortage status | Resolved |
Updated date | 2020-10-15 |
Company comments | Increase demand due to competitive shortage -Product on allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2020-10-15 | English | Compare |
v22 | 2020-10-15 | French | Compare |